On the contrary, FXR agonists increased the migration and invasion of pancreatic cancer cells, and FXR inhibition reduced cell proliferation of lung cancer cells in vitro as well as tumor growth in vivo in mice [207]. The gene discussed is NR1H4; the disease is pancreatic neoplasm.